CymaBay Therapeutics, Inc. (CBAY) Financials

Stock symbol CBAY is outdated, potentially delisted? Maybe it is available on other exchange?

CBAY Assets vs Liabilities

Date	Assets	Liabilities
Dec. 31, 2023	434.7 million	142.4 million
Sept. 30, 2023	451.0 million	124.9 million
June 30, 2023	226.7 million	118.2 million
March 31, 2023	245.3 million	141.1 million

CBAY Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Dec. 31, 2023	-27.6 million	4.7 million
Sept. 30, 2023	-26.1 million	3.7 million
June 30, 2023	-25.5 million	3.4 million
March 31, 2023	6.2 million	3.5 million

CBAY Net Income

No data available :(

CBAY Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Dec. 31, 2023	394.3 million	99.2 million	5.3 million
Sept. 30, 2023	438.8 million	104.1 million	206000
June 30, 2023	213.8 million	99.2 million	374000
March 31, 2023	236.4 million	94.6 million	537000

CBAY Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Dec. 31, 2023	113.3 million
Sept. 30, 2023	105.7 million
June 30, 2023	102.2 million
March 31, 2023	98.0 million

CBAY Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Dec. 31, 2023	180000	22.7 million	19.8 million	-
Sept. 30, 2023	-	20.0 million	12.2 million	-
June 30, 2023	70000	19.5 million	11.6 million	-
March 31, 2023	195000	18.6 million	8.3 million	-

CBAY Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Dec. 31, 2023	57000	56000
Sept. 30, 2023	-	215000
June 30, 2023	31.0 million	211000
March 31, 2023	-	199000

CBAY

Price: $32.48

52 week price:

7.26

32.50

Earnings Per Share: -0.93 USD

P/E Ratio: -34.58

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 528000

Ebitda: -8.0 million

Market Capitalization: 3.7 billion

Links:

CBAY on Yahoo Finance